Mindy Simpson to Male
This is a "connection" page, showing publications Mindy Simpson has written about Male.
Connection Strength
0.374
-
Using an educational intervention to assess and improve disease-specific knowledge and health literacy and numeracy in adolescents and young adults with haemophilia A and B. Haemophilia. 2021 Mar; 27(2):229-236.
Score: 0.057
-
Decreased Bleeding Rates in Patients with Hemophilia A Switching from Standard-Half-Life FVIII to BAY 94-9027 Prophylaxis. Thromb Haemost. 2021 08; 121(8):1079-1086.
Score: 0.056
-
Comparing Physician and Patient Perspectives on Prophylactic Treatment with BAY?94-9027 for Severe Haemophilia?A: A Post Hoc Analysis. Adv Ther. 2020 06; 37(6):2763-2776.
Score: 0.054
-
Comparing Factor Use and Bleed Rates in U.S. Hemophilia A Patients Receiving Prophylaxis with 3 Different Long-Acting Recombinant Factor VIII Products. J Manag Care Spec Pharm. 2020 Apr; 26(4):504-512.
Score: 0.053
-
Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis. J Thromb Haemost. 2018 01; 16(1):39-43.
Score: 0.023
-
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysis. Blood. 2017 10 12; 130(15):1757-1759.
Score: 0.022
-
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia A. Blood. 2017 03 09; 129(10):1245-1250.
Score: 0.021
-
Sickle Cell Trait Testing Should Not Be a Player in NCAA Athletics: Examining the Media's Role in Disseminating Awareness and Information. J Pediatr Hematol Oncol. 2018 07; 40(5):414-415.
Score: 0.012
-
Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors. Haemophilia. 2017 Nov; 23(6):844-851.
Score: 0.011
-
Bypassing agent prophylaxis in people with hemophilia A or B with inhibitors. Cochrane Database Syst Rev. 2017 09 25; 9:CD011441.
Score: 0.011
-
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding. Haemophilia. 2017 Nov; 23(6):832-843.
Score: 0.011
-
Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate(?) ) in patients with severe haemophilia A. Haemophilia. 2016 Sep; 22(5):730-8.
Score: 0.010
-
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A. N Engl J Med. 2016 May 26; 374(21):2054-64.
Score: 0.010
-
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the?Kids-DOTT trial): pilot/feasibility phase findings. J Thromb Haemost. 2015 Sep; 13(9):1597-605.
Score: 0.010
-
Use of global assays to understand clinical phenotype in congenital factor VII deficiency. Haemophilia. 2013 Sep; 19(5):765-72.
Score: 0.008
-
Vascular compromise as a cause of sudden death in a pediatric patient with widely metastatic testicular germ cell tumor. J Pediatr Hematol Oncol. 2009 Oct; 31(10):756-7.
Score: 0.006